Li GL - Search Results

1

Neuroprotective role of (Val(8))GLP-1-Glu-PAL in an in vitro model of Parkinson's disease.

Li L, Liu K, Zhao J, Holscher C, Li GL, Liu YZ. Li L, et al. Among authors: li gl. Neural Regen Res. 2016 Feb;11(2):326-31. doi: 10.4103/1673-5374.177742. Neural Regen Res. 2016. PMID: 27073388 Free PMC article.

2

Geniposide prevents rotenone-induced apoptosis in primary cultured neurons.

Li L, Zhao J, Liu K, Li GL, Han YQ, Liu YZ. Li L, et al. Among authors: li gl. Neural Regen Res. 2015 Oct;10(10):1617-21. doi: 10.4103/1673-5374.167760. Neural Regen Res. 2015. PMID: 26692859 Free PMC article.

3

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.

Ji C, Xue GF, Lijun C, Feng P, Li D, Li L, Li G, Hölscher C. Ji C, et al. Brain Res. 2016 Mar 1;1634:1-11. doi: 10.1016/j.brainres.2015.09.035. Epub 2015 Oct 11. Brain Res. 2016. PMID: 26453833 Free article.

4

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.

Cao L, Li D, Feng P, Li L, Xue GF, Li G, Hölscher C. Cao L, et al. Neuroreport. 2016 Apr 13;27(6):384-91. doi: 10.1097/WNR.0000000000000548. Neuroreport. 2016. PMID: 26918675

5

A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat.

Han L, Hölscher C, Xue GF, Li G, Li D. Han L, et al. Neuroreport. 2016 Jan 6;27(1):23-32. doi: 10.1097/WNR.0000000000000490. Neuroreport. 2016. PMID: 26555034

6

A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.

Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C. Yuan Z, et al. Eur J Pharmacol. 2017 Oct 5;812:82-90. doi: 10.1016/j.ejphar.2017.06.029. Epub 2017 Jun 27. Eur J Pharmacol. 2017. PMID: 28666800

7

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.

Feng P, Zhang X, Li D, Ji C, Yuan Z, Wang R, Xue G, Li G, Hölscher C. Feng P, et al. Neuropharmacology. 2018 May 1;133:385-394. doi: 10.1016/j.neuropharm.2018.02.012. Epub 2018 Feb 17. Neuropharmacology. 2018. PMID: 29462693 Free article.

8

The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke.

Yang X, Feng P, Zhang X, Li D, Wang R, Ji C, Li G, Hölscher C. Yang X, et al. Neuropharmacology. 2019 Nov 1;158:107748. doi: 10.1016/j.neuropharm.2019.107748. Epub 2019 Aug 26. Neuropharmacology. 2019. PMID: 31465784

9

Neuroprotective effects of geniposide on Alzheimer's disease pathology.

Liu W, Li G, Hölscher C, Li L. Liu W, et al. Rev Neurosci. 2015;26(4):371-83. doi: 10.1515/revneuro-2015-0005. Rev Neurosci. 2015. PMID: 25879319 Free article. Review.

10

Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease.

Ji C, Xue GF, Li G, Li D, Hölscher C. Ji C, et al. Rev Neurosci. 2016 Jan;27(1):61-70. doi: 10.1515/revneuro-2015-0021. Rev Neurosci. 2016. PMID: 26351802 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

777 results

Search Page

Filters